CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

KELEA Excellerated WaterWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D053120 Respiratory Aspiration NIH 0.32

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Can Inhalation of KELEA Excellerated Water Reduce the Time Required for Covid-19 Infected Individuals to Become Symptom-Free and PCR Negative

Preliminary reports have been received from several sources that the periodic inhaling of water with a heightened level of kinetic activity has lessened the severity of symptoms in Covid-19 infected patients. On at least several occasions, a repeat PCR test performed two days after inhaling a particular water-based product was negative. There are no perceived advese effects from inhaling the water using a nebulizer or humidifier. It is important, however, to validate these preliminary findings and to include other similar products in the testing

NCT04490824 Covid19 Device: KELEA Excellerated Water
MeSH:Respiratory Aspiration

Primary Outcomes

Description: Proportion of the PCR Positive Participants Who Become PCR Negative

Measure: Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Time: Two days of inhalation prior to the repeat PCR testing

Secondary Outcomes

Description: Proportion of the Symptomatic Participants Who Become Asymptomatic

Measure: Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Time: Symptoms prior to and after two days of inhalation

No related HPO nodes (Using clinical trials)